Citius Pharmaceuticals

About:

Citius Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapeutic products.

Website: http://www.citiuspharma.com

Twitter/X: citiuspharma

Top Investors: NJEDA, Leonard Mazur, Myron Holubiak

Description:

Citius Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapeutic products for large and growing markets. Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve market position or market exclusivity. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development. Citius is advancing two proprietary product candidates, our Mino-Lok™ product and a Hydrocortisone-Lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.

Total Funding Amount:

$184M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cranford, New Jersey, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)citiuspharma.com

Founders:

Leonard Mazur

Number of Employees:

11-50

Last Funding Date:

2024-11-15

IPO Status:

Public

Industries:

© 2025 bioDAO.ai